When Promising Treatments Are Left on the Shelf, Families Cannot Stay Silent
Of 659 rare disease trials examined, 30.2% were discontinued before completion. Patient organizations can help address this problem by connecting families with registries, researchers, and appropriate clinical trials. For parents
Read More » 
